Perspectives
Moderna’s mRNA-1010 Flu Shot Scores Phase 3 Triumph Amid Data Scrutiny and Political Undercurrents
A single datum can reshape public confidence overnight. On June 30, Moderna disclosed that its seasonal influenza candidate, mRNA-1010, achieved...
Read more
One Big Beautiful Bill: A Trillion-Dollar Strike Against Medicaid and Medicare
A single headline can tip the balance of millions of Americans’ access to care. On July 3, the U.S. Senate...
Read more
Milk Under Quarantine: How the H5N1 Dairy-Cow Outbreak Is Stress-Testing U.S. Biosecurity
Milk Under Quarantine Warm forage rarely figures in national conversation; nonetheless, by early July the smell of barn ventilation fans...
Read more
Why Patients Click Play: Trust, Philosophy, and the Allure of Health Videos
A tide of healthcare clips streams unceasingly on smartphones, offering patients bite-sized advice, procedural glimpses, and personal testimonials with the...
Read more
Visible Scars, Invisible Standards: Breast Reduction and the Online Reckoning with Body Image
The Body as Algorithmic Subject The footage begins plainly. A montage of clothing struggles, physical discomfort, and slouched posture. The...
Read more
When Cutting Calories Cuts Too Deep: Dieting’s Hidden Toll on Male Mental Health
The bathroom scale clicks down two pounds; the mood crashes by two stories. That paradox—celebrated waistline, sinking psyche—has haunted weight-loss...
Read more
GLP-1 Drugs & “Ozempic Teeth”: Myths, Missteps, and Medical Reality
A viral social-media rumor once claimed that Ozempic was eating people’s teeth—and just as viral reports suggest GLP-1 drugs may...
Read more
Crossing Borders: The Quiet Exodus of American Physicians to Canada
In recent months, a notable and unexpected phenomenon has quietly unfolded, reshaping conversations among medical professionals across North America. Prompted...
Read more
Physical Indicators of Dehydration in Medical Patients
Medical patients displaying the physical indicators of dehydration may also be experiencing medical abuse. Read this article to learn the...
Read more
Unseen Threats and Familiar Doubts: India’s Fresh Battle with the Omicron NB.1.8.1 Variant
As the sun rose over New Delhi in early May, the bustling city awoke to troubling headlines. COVID-19 was surging...
Read more
The Loneliness Cure: Why Social Connection May Be Medicine’s Most Underrated Intervention
The most potent threat to your health might not be high cholesterol, diabetes, or smoking—it might be loneliness. In a...
Read more
Rewriting the Standard: Why the Reaffirmation of Universal Syphilis Screening in Pregnancy Matters Now More Than Ever
In an era of high-tech diagnostics and billion-dollar biotech, the return of syphilis—an infection many assumed long subdued—feels both archaic...
Read more
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more